Skip to main content

Gilead’s Remdesivir Brought In $873 Million During The Third Quarter

Gilead reports quarterly earnings results.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.